TREA

87083450 - S

Follow

Information

  • Trademark
  • 87083450
  • Serial Number
    87083450
  • Filing Date
    June 24, 2016
    8 years ago
  • Transaction Date
    September 09, 2019
    5 years ago
  • Status Date
    September 09, 2019
    5 years ago
  • Published for Opposition Date
    June 13, 2017
    7 years ago
  • Location Date
    August 08, 2017
    7 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    FRUM MILONE, MARCIE R
  • Attorney Docket Number
    13288.101US1
    Attorney Name
    Scott W. Johnston
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
S
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of a stylized "S" made up of geometric shapes within a circle.
  • GS0011: Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals, namely, a chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices
  • GS0021: Medical device coatings; Coatings for biological and surgical implants, for providing a lubricious and biocompatible surface, sold separately from the implants; Coatings for medical devices, for delivery of a wide range of pharmaceuticals, sold separately from the medical devices; Chemical coatings used in the manufacture of medical devices; Medical device coatings for coronary, peripheral, neurovascular or heart devices; lubricious coatings for medical devices; Hemocompatible Coatings for medical devices
  • GS0051: Chemical preparations for medical purposes, namely, for coating medical devices and delivering medicine for the treatment of vascular disease; Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticals, cells and tissue; Chemical reagents for medical or veterinary purposes
  • GS0091: Microarray slides for scientific, laboratory or medical research use; beads, membranes, plates and surfaces for scientific research use; customizable polymer surfaces that immobilize or attach target biomolecules to the surface while preventing adsorption of unwanted biomolecules to the surface, sold as an integral component of all the aforesaid goods
  • GS0101: Medical devices and apparatus, namely, catheters and drug eluting balloon catheters; Medical devices, namely, stents that contain and deliver a wide range of pharmaceuticals; coatings for orthopedic implants, ocular implants and surgical implants comprised of artificial materials, sold as an integral part of the implants, for the delivery of a wide range of pharmaceuticals; Coatings sold as an integral component of medical stents and other implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; Medical devices, namely, coronary stent systems; Medical devices, namely, angioplasty catheters; Medical devices, namely, medical device Access systems; Medical devices, namely, chronic total occlusion devices; Medical devices, namely, embolic protection device; Medical devices, namely, hemostasis introducer sheath; Medical devices, namely, interventional micro-catheter
  • GS0401: Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others; consulting about custom manufacturing medical and surgical devices; consulting in the field of medical devices related to manufacturing coaxial guide catheters
  • GS0421: Research and development services in the field of chemical analysis tests and procedures; Research and development of new products for others in the fields of pharmaceuticals and medical and surgical devices; scientific and research consultation and product research in the fields of pharmaceuticals and medical and surgical devices; product development consultation in the fields of pharmaceuticals and medical and surgical devices; scientific and research consulting in the field of medical devices and medical device coatings and medical device drug delivery systems; scientific and research consulting in the fields of conducting medical pre-clinical studies and clinical trials; consulting in the field of quality control for medical devices and testing for quality control; Custom design of medical device coatings for others; Testing services for medical devices and medical device coatings; medical device testing for Durability, Shelf-life, aging studies process reproducibility, coating morphology consistency, Defect analysis, impurities, contaminants, drug release mechanisms; diagnostic services in the field of medical devices and coatings; Consulting in the field of medical devices related to design and development of coaxial guide catheter
  • PM0001: SURMODICS
Case File Event Statements
  • 9/9/2019 - 5 years ago
    43 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 9/9/2019 - 5 years ago
    42 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 2/12/2019 - 6 years ago
    41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/8/2019 - 6 years ago
    40 - EXTENSION 3 GRANTED Type: EX3G
  • 2/8/2019 - 6 years ago
    39 - EXTENSION 3 FILED Type: EXT3
  • 2/8/2019 - 6 years ago
    38 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/9/2018 - 6 years ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/7/2018 - 6 years ago
    36 - EXTENSION 2 GRANTED Type: EX2G
  • 8/7/2018 - 6 years ago
    35 - EXTENSION 2 FILED Type: EXT2
  • 8/7/2018 - 6 years ago
    34 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/1/2018 - 7 years ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/30/2018 - 7 years ago
    32 - EXTENSION 1 GRANTED Type: EX1G
  • 1/30/2018 - 7 years ago
    31 - EXTENSION 1 FILED Type: EXT1
  • 1/30/2018 - 7 years ago
    30 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/8/2017 - 7 years ago
    29 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/13/2017 - 7 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/13/2017 - 7 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/24/2017 - 7 years ago
    26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/6/2017 - 7 years ago
    25 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/28/2017 - 7 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/28/2017 - 7 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/28/2017 - 7 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/28/2017 - 7 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/28/2017 - 7 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/5/2017 - 7 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/4/2017 - 7 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/4/2017 - 7 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/27/2016 - 8 years ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/27/2016 - 8 years ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/27/2016 - 8 years ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/9/2016 - 8 years ago
    13 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 11/1/2016 - 8 years ago
    12 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 10/17/2016 - 8 years ago
    11 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/17/2016 - 8 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 9/30/2016 - 8 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/30/2016 - 8 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/30/2016 - 8 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/30/2016 - 8 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/30/2016 - 8 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/30/2016 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/30/2016 - 8 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 6/29/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/28/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP